SIL1 and hydrops fetalis: To support the hypothesis that the low Sil1 protein expression levels are due to post-translational degradation, we treated HF-P2 with the proteasomal inhibitor carbobenzoxy-L-leucyl-L-leucyl-L-leucinal (MG-132), which indeed significantly increased Sil1 expression (Figure 5A).